NACFC 2020: GI Manifestations in Cystic Fibrosis

(4:8)

NACFC 2020 | S06: Gene Editing Technologies for Understanding and Treatment of Disease

(1:29:51)

NACFC 2020: How Genetic-Based Therapies Could Restore CFTR Function

(3:55)

NACFC 2020 | S11: PT/RT Issues Across the Adult Lifespan: Transitions From Teens to the Elderly

(1:20:57)

NACFC 2020 | Plenary 1: Laying the Foundation for the Path to a Cure

(57:53)

NACFC 2020 | S18: Targeting Infection During Pulmonary Exacerbation Management

(1:12:58)

NACFC 2020 | Developing Innovative Gastroenterology Specialty Training Program

(3:47)

NACFC 2020 | S08: Addressing Women's Health in Cystic Fibrosis

(1:22:58)

NACFC 2020 | S01: Science of COVID-19 Infections and Treatments in Cystic Fibrosis

(1:6:11)

NACFC 2020 | S25: Management of GI Symptoms in Cystic Fibrosis

(1:16:6)

NACFC 2020 | Plenary 2: Defining the New CF in the Era of Highly Effective Modulators

(59:23)

NACFC 2020 | Workshop 1: Top 3 Abstracts in Path to a Cure

(44:7)

NACFC 2020 | S24: Leveraging Lung Biology: Gateway to Therapy for All

(1:18:8)

NACFC 2020 | S10: CFTR Modulators: What We Are Learning

(1:16:19)

NACFC 2020 | Plenary 3: Advancing the GI Frontier for People With CF

(51:4)

NACFC 2020 | Workshop 10: Top 3 Abstracts in Physical \u0026 Respiratory Therapy

(51:31)

NACFC 2020 | S04: Cystic Fibrosis-Related Diabetes Unresolved Clinical Questions

(1:20:11)

NACFC 2020 | S13: Ion Transport in Cystic Fibrosis Pathology

(1:22:18)

NACFC 2020 | Discipline Group 3: Beyond CF: A Spectrum of CFTR Variation \u0026 CFTR-opathies

(1:40:16)